Download PDF
Thromb Haemost 1980; 44(02): 105
DOI: 10.1055/s-0038-1650094
Letter of the Editor
Schattauer GmbH Stuttgart

Heparins and Release

Giuseppe Cella
University of Padua, Medical School Istituto di Semeiotica Medica Padua, Italy
,
Alessandra Casonato
University of Padua, Medical School Istituto di Semeiotica Medica Padua, Italy
,
Laura Visintin
University of Padua, Medical School Istituto di Semeiotica Medica Padua, Italy
,
Antonio Girolami
University of Padua, Medical School Istituto di Semeiotica Medica Padua, Italy
› Author Affiliations
Further Information

Publication History

Received 27 May 1980

Accepted 08 July 1980

Publication Date:
13 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Lane DA, McGregor IR, Michalski R, Kakkar VV. Anticoagulant activities of four unfractionated and fractionated heparins. Thromb Res 1978; 12: 257-271
    CrossrefPubMedGoogle Scholar
  • 2 Bell WR, Royall MR. Thrombocytopenia induced by heparin. A comparative study of three different heparin preparations. Blood 1979; 54 Suppl I 233a
    PubMedGoogle Scholar
  • 3 Cella G, Girolami A. Unpublished data
    PubMed
  • 4 Cella G, Menardo A, Girolami A. Effect of heparin on "in vivo" platelet factor 4 release and platelet aggregation after aspirin administration. Clin Lab Haemat 1980 (in press)
    PubMedGoogle Scholar
  • 5 DeMarco L, Fabris F, Molaro GL, Girolami A. The effect of heparin on the interaction of factor VIII and human platelets in vitro. Haemostasis 1977; 6: 163-170
    PubMedGoogle Scholar
  • 6 Dawes J, Smith RC, Pepper DS. The release, distribution and clearance of B-thromboglobulin and platelet factor 4. Thromb Res 1978; 12: 851-861
    CrossrefPubMedGoogle Scholar
  • 7 Girolami A, DeMarco L, Virgolini L, Peruffo R, Fabbri F. The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorder due to factor VIII or fibrinogen defect. Blut 1975; 31: 219-226
    CrossrefPubMedGoogle Scholar